<DOC>
	<DOCNO>NCT02229253</DOCNO>
	<brief_summary>Patients prostate cancer history cardiovascular disease treat degarelix prostate cancer , follow period one year . In real-life , non-interventional trial , cardiovascular event occur degarelix therapy document .</brief_summary>
	<brief_title>Real-life Data Cardiovascular Events Occuring During Degarelix Therapy Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patients prostate cancer history cardiovascular disease , prescribed degarelix treatment prostate cancer Patients receive form androgen deprivation therapy prostate cancer , 12 month precede study exclude Planned intermittent shortterm ( &lt; 12 month ) degarelix treatment Planned addition , switch another form androgen deprivation therapy study</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>